Prognosis and treatment of FOLFOX therapy related interstitial pneumonia : a plea for multimodal immune modulating therapy in the respiratory insufficient patient Ghent University University of Antwerp
Background: The FOLFOX regimen, i.e., folinic acid (FOL), fluorouracil (F) and oxaliplatin (OX), is a drug cocktail that is used to treat gastric and colorectal cancers. Despite the concomitant improvements in response rate, duration of response and patient survival, reports of serious toxic pulmonary side effects have progressively emerged. Case presentation: We describe a patient who was treated with FOLFOX as an adjuvant to a rectosigmoidal ...